Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital. / Pall, Amalie Hartvig; Lomholt, Anne Fog; Buchwald, Christian von; Bygum, Anette; Rasmussen, Eva Rye.

In: Journal of Asthma and Allergy, Vol. 13, 07.2020, p. 225-236.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Pall, AH, Lomholt, AF, Buchwald, CV, Bygum, A & Rasmussen, ER 2020, 'Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital', Journal of Asthma and Allergy, vol. 13, pp. 225-236. https://doi.org/10.2147/JAA.S245161

APA

Pall, A. H., Lomholt, A. F., Buchwald, C. V., Bygum, A., & Rasmussen, E. R. (2020). Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital. Journal of Asthma and Allergy, 13, 225-236. https://doi.org/10.2147/JAA.S245161

Vancouver

Pall AH, Lomholt AF, Buchwald CV, Bygum A, Rasmussen ER. Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital. Journal of Asthma and Allergy. 2020 Jul;13:225-236. https://doi.org/10.2147/JAA.S245161

Author

Pall, Amalie Hartvig ; Lomholt, Anne Fog ; Buchwald, Christian von ; Bygum, Anette ; Rasmussen, Eva Rye. / Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital. In: Journal of Asthma and Allergy. 2020 ; Vol. 13. pp. 225-236.

Bibtex

@article{086d4dca332d4952abc97b59d8d505cd,
title = "Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital",
abstract = "Purpose: To give a better understanding of primary AE, the clinical characteristics and the possible therapeutic approaches. Background: Angioedema (AE) is a non-pitting, non-itching swelling of skin or mucosa. The symptom can become life-threatening if located in the airways. Primary (monosympto-matic) AE is a manifestation of several different diseases and the diagnosis is not always straight-forward. The aetiological and pathophysiological factors of primary AE are not completely clarified. There is a need for further investigation. Patients and Methods: This was a retrospective cohort study of patients referred to an outpatient dermatology clinic in a tertiary care hospital for clinical assessment due to primary AE in the period from 1996 to 2014. Results: A total of 315 patients were identified with primary AE. The most frequent subtype was idiopathic AE (42.5%) and the second most common was angiotensin-converting enzymeinhibitor (ACEi)-induced AE (31.1%). Three patients were diagnosed with hereditary AE and one patient was diagnosed with acquired C1-inhibitor deficiency. At least 107 (34.0%) patients had established histaminergic AE. More than 1/3 of the patients were treated in an emergency room or hospitalized due to AE. A 98.1% of patients had experienced AE in the head and neck area. Seven patients were in the need of acute airway intervention. Six of these had ACEi-induced AE. Female sex and smoking were found to be risk factors for developing AE. Conclusion: The most frequent diagnoses were histaminergic-, non-histaminergic idiopathic AE and ACEi-induced AE, whereas complement C1-inhibitor deficiency was rare. Histaminergic AE made up a substantial group of patients with primary AE. Even though there are different pathophysiological causes of AE, many cases have overlapping clinical manifestations, which make diagnosis and treatment difficult.",
keywords = "Angiotensin-converting enzyme inhibitors, Bradykinin, Hereditary angioedema, Primary angioedema, Urticaria",
author = "Pall, {Amalie Hartvig} and Lomholt, {Anne Fog} and Buchwald, {Christian von} and Anette Bygum and Rasmussen, {Eva Rye}",
year = "2020",
month = jul,
doi = "10.2147/JAA.S245161",
language = "English",
volume = "13",
pages = "225--236",
journal = "Journal of Asthma and Allergy",
issn = "1178-6965",
publisher = "Dove Medical Press Ltd",

}

RIS

TY - JOUR

T1 - Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital

AU - Pall, Amalie Hartvig

AU - Lomholt, Anne Fog

AU - Buchwald, Christian von

AU - Bygum, Anette

AU - Rasmussen, Eva Rye

PY - 2020/7

Y1 - 2020/7

N2 - Purpose: To give a better understanding of primary AE, the clinical characteristics and the possible therapeutic approaches. Background: Angioedema (AE) is a non-pitting, non-itching swelling of skin or mucosa. The symptom can become life-threatening if located in the airways. Primary (monosympto-matic) AE is a manifestation of several different diseases and the diagnosis is not always straight-forward. The aetiological and pathophysiological factors of primary AE are not completely clarified. There is a need for further investigation. Patients and Methods: This was a retrospective cohort study of patients referred to an outpatient dermatology clinic in a tertiary care hospital for clinical assessment due to primary AE in the period from 1996 to 2014. Results: A total of 315 patients were identified with primary AE. The most frequent subtype was idiopathic AE (42.5%) and the second most common was angiotensin-converting enzymeinhibitor (ACEi)-induced AE (31.1%). Three patients were diagnosed with hereditary AE and one patient was diagnosed with acquired C1-inhibitor deficiency. At least 107 (34.0%) patients had established histaminergic AE. More than 1/3 of the patients were treated in an emergency room or hospitalized due to AE. A 98.1% of patients had experienced AE in the head and neck area. Seven patients were in the need of acute airway intervention. Six of these had ACEi-induced AE. Female sex and smoking were found to be risk factors for developing AE. Conclusion: The most frequent diagnoses were histaminergic-, non-histaminergic idiopathic AE and ACEi-induced AE, whereas complement C1-inhibitor deficiency was rare. Histaminergic AE made up a substantial group of patients with primary AE. Even though there are different pathophysiological causes of AE, many cases have overlapping clinical manifestations, which make diagnosis and treatment difficult.

AB - Purpose: To give a better understanding of primary AE, the clinical characteristics and the possible therapeutic approaches. Background: Angioedema (AE) is a non-pitting, non-itching swelling of skin or mucosa. The symptom can become life-threatening if located in the airways. Primary (monosympto-matic) AE is a manifestation of several different diseases and the diagnosis is not always straight-forward. The aetiological and pathophysiological factors of primary AE are not completely clarified. There is a need for further investigation. Patients and Methods: This was a retrospective cohort study of patients referred to an outpatient dermatology clinic in a tertiary care hospital for clinical assessment due to primary AE in the period from 1996 to 2014. Results: A total of 315 patients were identified with primary AE. The most frequent subtype was idiopathic AE (42.5%) and the second most common was angiotensin-converting enzymeinhibitor (ACEi)-induced AE (31.1%). Three patients were diagnosed with hereditary AE and one patient was diagnosed with acquired C1-inhibitor deficiency. At least 107 (34.0%) patients had established histaminergic AE. More than 1/3 of the patients were treated in an emergency room or hospitalized due to AE. A 98.1% of patients had experienced AE in the head and neck area. Seven patients were in the need of acute airway intervention. Six of these had ACEi-induced AE. Female sex and smoking were found to be risk factors for developing AE. Conclusion: The most frequent diagnoses were histaminergic-, non-histaminergic idiopathic AE and ACEi-induced AE, whereas complement C1-inhibitor deficiency was rare. Histaminergic AE made up a substantial group of patients with primary AE. Even though there are different pathophysiological causes of AE, many cases have overlapping clinical manifestations, which make diagnosis and treatment difficult.

KW - Angiotensin-converting enzyme inhibitors

KW - Bradykinin

KW - Hereditary angioedema

KW - Primary angioedema

KW - Urticaria

UR - http://www.scopus.com/inward/record.url?scp=85088485270&partnerID=8YFLogxK

U2 - 10.2147/JAA.S245161

DO - 10.2147/JAA.S245161

M3 - Journal article

C2 - 32764994

AN - SCOPUS:85088485270

VL - 13

SP - 225

EP - 236

JO - Journal of Asthma and Allergy

JF - Journal of Asthma and Allergy

SN - 1178-6965

ER -

ID: 249528033